Peripheral Stent Market Size, Share, Trends, Growth Outlook

Peripheral Stent Market is estimated to increase at a Compounded Annual Growth Rate of 7.2% CAGR over the forecast period from 2024 to 2030

The Peripheral Stent Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Bare Metal Stents (BMS), Covered Stents, Drug Eluting Stents (DES)), By Artery (Iliac stents, Femoral-popliteal stents, Renal & related Artery stents, Carotid stents), By End-User (Hospitals, Ambulatory Surgical Centers).

An Introduction to Peripheral Stent Market in 2024

In 2024, the market for peripheral stents continues to expand, driven by the increasing incidence of peripheral artery disease (PAD), atherosclerosis, and other vascular conditions affecting the peripheral arteries, which require intervention to restore blood flow and prevent limb ischemia. Peripheral stents are small, expandable metal or polymer tubes used to prop open narrowed or blocked arteries in the peripheral vascular system, facilitating blood flow and relieving symptoms such as claudication, pain, and tissue ischemia. The market for peripheral stents encompasses a variety of stent types, including bare-metal stents, drug-eluting stents, and bioresorbable stents, each with unique features and indications for use in different anatomical locations and lesion characteristics. Peripheral stents are commonly used in the treatment of peripheral artery disease, iliac artery stenosis, femoropopliteal disease, and below-the-knee artery occlusions, either as a standalone therapy or in conjunction with other endovascular procedures such as angioplasty and atherectomy. Technological advancements in peripheral stent design focus on improving stent flexibility, radial strength, and resistance to fracture, as well as reducing the risk of restenosis and thrombosis through the use of advanced stent coatings, drug-delivery platforms, and bioactive materials. Moreover, the integration of advanced imaging techniques such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) enables precise stent placement, lesion assessment, and post-procedural evaluation, optimizing treatment outcomes and reducing the need for repeat interventions. With the increasing prevalence of peripheral artery disease and the aging population, the market for peripheral stents is poised for continued growth and innovation, offering patients and healthcare providers advanced endovascular solutions for restoring blood flow, preserving limb function, and improving quality of life in peripheral vascular disease patients.

Market Trend: Advancements in Stent Technology

A prominent trend in the Peripheral Stent market is the continuous advancements in stent technology. Stents are increasingly being used in the treatment of peripheral artery disease (PAD) and other vascular conditions to restore blood flow and prevent complications such as limb ischemia and amputation. Recent innovations in stent design, materials, and coatings aim to improve stent flexibility, radial strength, and biocompatibility while reducing the risk of restenosis and thrombosis. Additionally, the development of drug-eluting stents and bioresorbable stents offers new possibilities for targeted drug delivery and long-term vascular healing. This trend reflects a commitment to improving patient outcomes and enhancing the efficacy and safety of peripheral stent procedures through technological innovation and optimization.

Market Driver: Rising Prevalence of Peripheral Artery Disease

A primary driver fueling the growth of the Peripheral Stent market is the rising prevalence of peripheral artery disease (PAD) and other peripheral vascular conditions. PAD, characterized by narrowing or blockage of arteries in the legs, arms, or other peripheral areas, is a common manifestation of atherosclerosis and a significant cause of morbidity and mortality worldwide. Factors such as aging populations, sedentary lifestyles, smoking, diabetes, and obesity contribute to the increasing incidence and prevalence of PAD and related vascular conditions. As the burden of PAD grows, there is a corresponding increase in the demand for minimally invasive interventions such as peripheral stenting to restore blood flow, relieve symptoms, and improve quality of life for patients with peripheral vascular disease.

Market Opportunity: Expansion into Emerging Markets and Indications

An emerging opportunity in the Peripheral Stent market lies in the expansion into emerging markets and indications. While peripheral stenting is well-established for the treatment of PAD in major arteries such as the iliac and femoral arteries, there is potential for growth in emerging markets and indications such as below-the-knee (BTK) arteries, superficial femoral arteries (SFA), and renal arteries. Additionally, opportunities exist for peripheral stenting in non-atherosclerotic conditions such as venous diseases, arteriovenous malformations, and intracranial vascular lesions. By expanding the use of peripheral stents into new markets and indications, medical device companies can capitalize on untapped opportunities, address unmet medical needs, and drive growth in the peripheral stent market.

Peripheral Stent Market Share Analysis: Drug Eluting Stents (DES)

Among the various products, arteries, and end-users in the peripheral stent market, drug eluting stents (DES) for the femoral-popliteal artery are experiencing rapid growth. The femoral-popliteal artery is a common location for peripheral artery disease (PAD), which can lead to symptoms such as leg pain, claudication, and limb ischemia. DES are stents coated with medications that are slowly released into the artery to prevent restenosis, or the re-narrowing of the artery, which is a common complication following stent placement. In the femoral-popliteal artery, where there is a high mechanical stress environment due to movement and bending of the leg, DES have demonstrated superior outcomes compared to bare metal stents (BMS) and covered stents. DES help to inhibit the proliferation of smooth muscle cells and reduce the risk of restenosis, thereby improving long-term patency rates and reducing the need for repeat interventions. As the prevalence of PAD and the demand for minimally invasive treatment options continue to rise, there is growing adoption of DES for femoral-popliteal artery interventions by healthcare providers, including hospitals and ambulatory surgical centers. Moreover, advancements in stent design, drug coatings, and delivery systems are further driving the growth of DES in the peripheral stent market. As DES technology continues to evolve and clinical evidence supporting their efficacy accumulates, the market for DES for femoral-popliteal artery interventions is expected to witness significant growth in the peripheral stent market.

Peripheral Stent Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corp, Cook Medical LLC, Hellman & Friedman LLC, iVascular S.L.U., Lifetech Scientific (Shenzhen) Co. Ltd, Medtronic plc, MicroPort Scientific Corp, Stentys S.A., Stryker Corp, Terumo Medical Corp

Peripheral Stent Market Segmentation

By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Peripheral Stent Market Companies

Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corp
Cook Medical LLC
Hellman & Friedman LLC
iVascular S.L.U.
Lifetech Scientific (Shenzhen) Co. Ltd
Medtronic plc
MicroPort Scientific Corp
Stentys S.A.
Stryker Corp
Terumo Medical Corp

Reasons to Buy the Peripheral Stent Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Peripheral Stent Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Peripheral Stent Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Peripheral Stent Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Peripheral Stent Market Size Outlook, $ Million, 2021 to 2030
3.2 Peripheral Stent Market Outlook by Type, $ Million, 2021 to 2030
3.3 Peripheral Stent Market Outlook by Product, $ Million, 2021 to 2030
3.4 Peripheral Stent Market Outlook by Application, $ Million, 2021 to 2030
3.5 Peripheral Stent Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Peripheral Stent Industry
4.2 Key Market Trends in Peripheral Stent Industry
4.3 Potential Opportunities in Peripheral Stent Industry
4.4 Key Challenges in Peripheral Stent Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Peripheral Stent Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Peripheral Stent Market Outlook by Segments
7.1 Peripheral Stent Market Outlook by Segments, $ Million, 2021- 2030
By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers

8 North America Peripheral Stent Market Analysis and Outlook To 2030
8.1 Introduction to North America Peripheral Stent Markets in 2024
8.2 North America Peripheral Stent Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Peripheral Stent Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers

9 Europe Peripheral Stent Market Analysis and Outlook To 2030
9.1 Introduction to Europe Peripheral Stent Markets in 2024
9.2 Europe Peripheral Stent Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Peripheral Stent Market Size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers

10 Asia Pacific Peripheral Stent Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Peripheral Stent Markets in 2024
10.2 Asia Pacific Peripheral Stent Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Peripheral Stent Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers

11 South America Peripheral Stent Market Analysis and Outlook To 2030
11.1 Introduction to South America Peripheral Stent Markets in 2024
11.2 South America Peripheral Stent Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Peripheral Stent Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers
12 Middle East and Africa Peripheral Stent Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Peripheral Stent Markets in 2024
12.2 Middle East and Africa Peripheral Stent Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Peripheral Stent Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corp
Cook Medical LLC
Hellman & Friedman LLC
iVascular S.L.U.
Lifetech Scientific (Shenzhen) Co. Ltd
Medtronic plc
MicroPort Scientific Corp
Stentys S.A.
Stryker Corp
Terumo Medical Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
By Artery
Iliac stents
Femoral-popliteal stents
Renal & related Artery stents
Carotid stents
By End-User
Hospitals
Ambulatory Surgical Centers
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)